AU2001227744A1 - Osmotic device containing ranitidine and a prokinetic agent - Google Patents

Osmotic device containing ranitidine and a prokinetic agent

Info

Publication number
AU2001227744A1
AU2001227744A1 AU2001227744A AU2774401A AU2001227744A1 AU 2001227744 A1 AU2001227744 A1 AU 2001227744A1 AU 2001227744 A AU2001227744 A AU 2001227744A AU 2774401 A AU2774401 A AU 2774401A AU 2001227744 A1 AU2001227744 A1 AU 2001227744A1
Authority
AU
Australia
Prior art keywords
device containing
osmotic device
prokinetic agent
containing ranitidine
ranitidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001227744A
Other languages
English (en)
Inventor
Joaquina Faour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osmotica Corp
Original Assignee
PHOENIX USA Inc LAB
Laboratorios Phoenix USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHOENIX USA Inc LAB, Laboratorios Phoenix USA Inc filed Critical PHOENIX USA Inc LAB
Publication of AU2001227744A1 publication Critical patent/AU2001227744A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001227744A 2000-01-13 2001-01-09 Osmotic device containing ranitidine and a prokinetic agent Abandoned AU2001227744A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17584400P 2000-01-13 2000-01-13
US60175844 2000-01-13
PCT/US2001/000610 WO2001051039A1 (fr) 2000-01-13 2001-01-09 Dispositif osmotique contenant du ranitidine et un agent procinetique

Publications (1)

Publication Number Publication Date
AU2001227744A1 true AU2001227744A1 (en) 2001-07-24

Family

ID=22641875

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001227744A Abandoned AU2001227744A1 (en) 2000-01-13 2001-01-09 Osmotic device containing ranitidine and a prokinetic agent

Country Status (4)

Country Link
AR (1) AR026837A1 (fr)
AU (1) AU2001227744A1 (fr)
UY (1) UY26537A1 (fr)
WO (1) WO2001051039A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1103093A2 (pt) * 2011-06-03 2013-07-02 Eurofarma Laboratarios Ltda composiÇço farmacÊutica oral e uso da composiÇço farmacÊutica oral

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI9802144B1 (pt) * 1997-05-30 2017-03-28 Ezequiel Mayorga Jorge dispositivo osmótico multicapa aperfeiçoado

Also Published As

Publication number Publication date
AR026837A1 (es) 2003-02-26
UY26537A1 (es) 2001-07-31
WO2001051039A1 (fr) 2001-07-19

Similar Documents

Publication Publication Date Title
AU2001227702A1 (en) Osmotic device within an osmotic device
AU2001226349A1 (en) Osmotic device containing pseudoephedrine and an h1 antagonist
AU2001227731A1 (en) Osmotic device containing venlafaxine and an anti-psychotic agent
AU2001227758A1 (en) Osmotic device containing alprazolam and an antipsychotic agent
GB0302415D0 (en) Antimicrobial agent
AU2758701A (en) Storage device
AU2002216555A1 (en) A delivery device
AU2001264968A1 (en) Filling device
AU2001291542A1 (en) Jigsaw puzzle
AU2001294482A1 (en) A delivery device
AU6261601A (en) A jigsaw puzzle system
AU2001296110A1 (en) A delivery device
AU2001252418A1 (en) Nasal packing device
AU2002215182A1 (en) Pressurization device
GB0004771D0 (en) A novelty device
AU2002214176A1 (en) Stop device
AU2001227744A1 (en) Osmotic device containing ranitidine and a prokinetic agent
EP1291461A4 (fr) Recuperateur de couleur
IL145273A0 (en) Reeder rotator
GB0013400D0 (en) A formulation
AU2001250041A1 (en) Noisemaking device
AU2002214990A1 (en) Storage device
IL153245A0 (en) New formulation comprising a betablocker and optionally a cholesterol-lowering agent
AU2002221661A1 (en) Strapping device
AU2001276263A1 (en) Game device